Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies. [PDF]
Kageyama K, Sato K, Tasso M, Nakada Y.
europepmc +1 more source
Sustained remission of post-Fontan protein-losing enteropathy achieved by combination therapy with high-dose spironolactone and the somatostatin analogue octreotide: a case report. [PDF]
Suzuki E +10 more
europepmc +1 more source
Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II. [PDF]
Parte S +4 more
europepmc +1 more source
Feature-tuned excitation of somatostatin interneurons drives figure-ground segregation. [PDF]
Zhang YE, Tao HW.
europepmc +1 more source
Case Report: Treatment of hypersomatotropism in a diabetic dog with transsphenoidal hypophysectomy. [PDF]
Meij AS +6 more
europepmc +1 more source
Targeting Peptidergic Systems for Melanoma Treatment. [PDF]
Sánchez ML, Mehboob R, Coveñas R.
europepmc +1 more source
Clinical Value of ¹⁸F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Neuroendocrine Neoplasms: A Case Report and Literature Review. [PDF]
Gutierrez Albenda D +4 more
europepmc +1 more source
Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors. [PDF]
de Almeida GR +6 more
europepmc +1 more source
Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials. [PDF]
Ribeiro Junior MAF +9 more
europepmc +1 more source
Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndrome.
Cole Y +10 more
europepmc +1 more source

